​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

Modernization
Workgroups
Memorandums
Payers
Legal and Legislative
Acct and Budget Manual
Data Request
Patient Complaint Information
Trustee Disclosure Information
ED Wait Time Reduction Commission

HSCRC Overview

Welcome to the HSCRC
The Maryland Health Services Cost Review Commission (HSCRC) is an independent state agency ensuring all Marylanders have access to high-value, affordable healthcare. We regulate hospital rates, advance health system transformation, and support the innovative AHEAD Model to improve care quality, health outcomes, and cost-efficiency.​​​​  Lear​n More about the AHEAD Model.​
​Notices: 
NOTICE OF WRITTEN COMMENT PERIOD

Notice is hereby given that the public and interested parties are invited to submit written comments to the Commission on the following topic: 

In the Budget Reconciliation and Financing Act (BRFA) of 2026 the Maryland General Assembly charged the HSCRC with evaluating whether financial assistance to Medicare Advantage plans is required to maintain the viability of the plans in calendar year 2026, and whether hospital rates should be adjusted to provide financial assistance.

WRITTEN COMMENTS ON THE QUESTIONS OUTLINED BELOW SHALL BE SUBMITTED TO [email protected] ON OR BEFORE FRIDAY, OCTOBER 30, 2026.​

  1. ​What financial metrics should be considered to determine the financial status for Maryland Medicare Advantage plans in calendar year 2026?
  2. How should ‘viability’ be defined, and what metrics should be considered in evaluating plan viability for calendar year 2026?
  3. If financial assistance is determined to be necessary to maintain the viability of plans, how should financial assistance be distributed, and what eligibility criteria should be required for MA plans to receive support?
  4. What considerations should the Commission evaluate when determining whether hospital rates should be used to provide such financial assistance?
  5. The HSCRC has also received enquiries about I-SNP Plans, should I-SNPs be eligible for inclusion in the Medicare Advantage Stabilization Program and what considerations should the Commission evaluate when determining whether I-SNPs should be included?


​Stay Connected​
Have questions or suggestions? We’re here to help. Contact Us​
Cell and Gene Therapy Access Model
Mar​yland Medicaid is participating in CMS' Cell and Gene Therapy Access Model. Learn more.​​

Health Services Cost Review Commission
4160 Patterson Avenue
Baltimore, Maryland 21215
Phone: 410.764.2605
Fax: 410.358.6217